PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Pentosan polysulfate sodium - Glycosaminoglycan layer therapy (GAG therapy)

PAD Profile : Pentosan polysulfate sodium - Glycosaminoglycan layer therapy (GAG therapy) Important

Keywords :
bladder pain syndrome, interstitial cystitis
Brand Names Include :
Elmiron
Important Information :
Urology consultants only

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Capsules
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
R
NICE
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
13 February 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Area Prescribing Committee recommends Pentosan Polysulfate Sodium as a treatment option for bladder pain syndrome in line with NICE guidance (NICE TA 610)

Pentosan Polysulfate Sodium for this indication will be considered RED on the traffic light system. Pentosan is recommended by NICE for use in secondary care only

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication

Associated BNF Codes

07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.03. Drugs used in urological pain
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More